FEB 23, 2020 7:33 PM PST

Celular aging reexamined

New research published in Genes and Development has identified one of the mysteries of aging. According to scientists at Sanford Burnham Prebys Medical Discovery Institute and Harvard University, mitochondria trigger senescence. Senescence refers to the sleep-like state of aged cells.

In addition to this discovery, the recent study also reports that an already FDA-approved drug could suppress senescence, which has significant implications for diseases related to aging such as cancer, Alzheimer's disease, heart disease, among others.

Senior author Peter Adams, Ph.D., is a professor in Sanford Burnham Prebys' National Cancer Institute (NCI)-designated Cancer Center. He commented, "Our findings provide a foundation upon which we can start to develop drugs that extend our health span -- the number of years we live a healthy life. Given the major social and economic hurdles we will soon face as millions of Americans grow older, interventions can't come soon enough."

In conducting their study, the researchers modeled senescence in human lung cells. They were able to identify mitochondria as the driver of certain inflammatory signals through its communication with the nucleus. Such inflammatory responses are associated with several negative health effects.

"In school we learned that the role of mitochondria is to generate energy -- and that DNA controls everything the cell does," explains Adams. "Research is now showing that mitochondria are important sensors for the cell and have a lot of cross-talk with the nucleus, which makes sense given their duty to respond to the cell's metabolic needs."

Photo: Pixabay

Furthermore, the team showed that an HDAC inhibitor drug that is currently used to treat some cancers is capable of suppressing senescence by changing cells’ shapes. Interestingly, the scientists observed that senescent cells administered the drug generated fewer inflammatory signals. They hope to continue investigating senescence-inhibiting drugs at the Institute's Conrad Prebys Center for Chemical Genomics.

"This study provides the first concrete link between several known hallmarks of aging -- dysfunctional mitochondria, inflammation, and senescent cells -- which historically were studied as separate events," says Adams. "We are hopeful that targeting the molecular drivers of senescence will lead us to safe and effective medicines that help more people stay as healthy as possible, for as long as possible."

Sources: Genes and Development, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUL 08, 2021
Genetics & Genomics
Is It Possible to Prevent Leukemia in Down Syndrome Patients?
JUL 08, 2021
Is It Possible to Prevent Leukemia in Down Syndrome Patients?
Children with Down syndrome have a significantly higher likelihood myeloid leukemia occurring in the first five years of ...
JUL 23, 2021
Cancer
New Drug Eradicates Breast Cancer Tumors in Days
JUL 23, 2021
New Drug Eradicates Breast Cancer Tumors in Days
A new drug can kill between 95 and 100% of cancer cells in mice with human estrogen-receptor-positive breast cancer. The ...
AUG 20, 2021
Drug Discovery & Development
Blood Pressure Drugs Boost Survival in Colorectal Cancer
AUG 20, 2021
Blood Pressure Drugs Boost Survival in Colorectal Cancer
Common drugs used to regulate blood pressure may improve survival rates among patients with colorectal cancer, also know ...
AUG 24, 2021
Technology
CRISPR Helps Identify New Therapeutic Target for Leukemia
AUG 24, 2021
CRISPR Helps Identify New Therapeutic Target for Leukemia
Researchers may have found a new druggable target in patients with acute myeloid leukemia (AML), thanks to a CRISPR scre ...
NOV 11, 2021
Clinical & Molecular DX
Cancer Pathologist Burnout? AI to the Rescue.
NOV 11, 2021
Cancer Pathologist Burnout? AI to the Rescue.
Diagnosing cancer is hard work. The challenging demands of their caseloads see diagnostic pathologists in many clinical ...
NOV 14, 2021
Genetics & Genomics
Cancer Drug Target Could Actually Worsen Disease
NOV 14, 2021
Cancer Drug Target Could Actually Worsen Disease
Cancer drugs have been developed that target an enzyme, Shp2. But that enzyme has a more complex role than we knew.
Loading Comments...